固体瘤的树突细胞免疫疗法:翻译研究和临床应用的进展
1Department of Biological Science, Immunology Research Lab & BK21-Four Educational Research Group for Age-Associated Disorder Control Technology, Chosun University, Gwangju 61452, Republic of Korea.
Current issues in molecular biology
|October 28, 2025
概括
树突细胞 (DC) 免疫疗法在固体瘤中显示出有前途,进步提高了疫苗的疗效. 克服瘤微环境等挑战是将DC疫苗整合到精确瘤学的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 疫苗学 疫苗学 疫苗学
背景情况:
- 树突细胞 (DCs) 是关键的抗原呈现细胞,弥合了先天性和适应性免疫.
- DCs对于开发有效的癌症免疫疗法至关重要,特别是在固体瘤中.
研究的目的:
- 审查最近在树突细胞 (DC) 基免疫治疗固体瘤的进展.
- 讨论DC疫苗开发中的转化影响和挑战.
主要方法:
- 对黑色素瘤,质母细胞瘤,前列腺癌和非小细胞肺癌的临床研究的综述.
- 分析增强DC疫苗疗效的策略,包括抗原输送和辅助剂设计.
- 探索克服翻译障碍的解决方案.
主要成果:
- 在临床试验中,DC接种疫苗证明了安全性和免疫性.
- 组合疗法 (例如,免疫检查点阻塞,新抗原) 显示出令人鼓舞的疗效.
- 在体内向,生物材料,单细胞分析和人工智能的进步有助于AI的发展.
结论:
- 电流免疫疗法是固体瘤精密瘤学的基本要素.
- 目前正在进行的创新旨在将个性化DC疫苗接种纳入标准癌症护理.
- 解决瘤微环境和制造变异性对于临床成功至关重要.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines
946
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
946


